RGNX short interest
REGENXBIO Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 9,608,992 |
|---|---|
| Change vs prior report | 1,681,389 (+21.2%) |
| Change over six months | +43.2% |
| Days to cover | 5.99 (sector: 3.78) |
| Average daily volume | 1,603,635 |
| Rank in Healthcare | #323 of 922 by days to cover |
RGNX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 9,608,992 | +21.2% | 5.99 | 1,603,635 |
| 2026-09-15 | 7,927,603 | +5.7% | 7.66 | 1,034,298 |
| 2026-08-31 | 7,497,221 | -8.5% | 4.87 | 1,540,035 |
| 2026-08-14 | 8,197,515 | +13.9% | 7.77 | 1,055,416 |
| 2026-07-31 | 7,194,939 | -16.6% | 3.79 | 1,897,130 |
| 2026-07-15 | 8,626,772 | -17.5% | 3.29 | 2,618,877 |
| 2026-06-30 | 10,459,575 | +12.9% | 3.19 | 3,279,369 |
| 2026-06-15 | 9,263,377 | +11.8% | 6.96 | 1,331,564 |
| 2026-05-29 | 8,281,637 | +16.1% | 4.50 | 1,838,381 |
| 2026-05-15 | 7,135,749 | +6.6% | 3.19 | 2,233,461 |
| 2026-04-30 | 6,692,556 | -3.6% | 12.13 | 551,882 |
| 2026-04-15 | 6,943,990 | +3.5% | 12.63 | 549,704 |
| 2026-03-31 | 6,710,934 | +3.8% | 8.08 | 830,357 |
| 2026-03-13 | 6,468,047 | +1.3% | 5.70 | 1,135,717 |
| 2026-02-27 | 6,386,587 | +6.5% | 9.05 | 705,539 |
| 2026-02-13 | 5,998,350 | +23.0% | 5.58 | 1,074,799 |
| 2026-01-30 | 4,876,066 | -4.8% | 3.63 | 1,344,527 |
| 2026-01-15 | 5,123,815 | +3.1% | 6.89 | 743,943 |
| 2025-12-31 | 4,968,961 | -2.7% | 7.31 | 679,436 |
| 2025-12-15 | 5,107,325 | -5.8% | 7.73 | 661,080 |
| 2025-11-28 | 5,424,408 | +14.4% | 7.88 | 688,096 |
| 2025-11-14 | 4,741,368 | +4.2% | 8.21 | 577,203 |
| 2025-10-31 | 4,548,522 | -6.8% | 8.64 | 526,229 |
| 2025-10-15 | 4,880,756 | -2.1% | 7.13 | 684,848 |
| 2025-09-30 | 4,984,961 | -1.6% | 9.62 | 518,063 |
import finzdata as yf
yf.Ticker("RGNX").short_interest # every report since 2017
yf.Client().short_interest(["RGNX"], start="2018-01-01")Healthcare short interest · RGNX price history · Who owns RGNX · All short interest